|
Pfizer wins right to challenge Prempro damages award; Asthma market flat until …
FiercePharma Item > The asthma drug market will remain flat at around $14.4 billion through 2020, thanks in part to generic rivals for Merck's ($MRK)Singulair, Decision Resources concludes. Release > Teva Pharmaceutical Industries ($TEVA) won an appeals court's … |
View full post on asthma – Google News